Legal status · United Kingdom
Is AZD6234 legal in the United Kingdom?
No. AZD6234 is not approved for any medical use in the United Kingdom; its classification is "Investigational, not licensed". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.
AZD6234 in the United Kingdom at a glance
| Classification | Investigational, not licensed |
|---|---|
| MHRA approval status | Not approved by MHRA; investigational |
| Evidence level | Preliminary (research strength: Preliminary) |
| Reviewed | Sep 2026 |
Classification and note come from the AZD6234 profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
AZD6234 is being studied in registered clinical trials but has not received MHRA marketing approval in the United Kingdom.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What AZD6234 is
AstraZeneca's weekly amylin analog that jumped to Phase 3 in 2026 as a monotherapy and as an add-on to GLP-1 drugs, with detailed Phase 2 numbers still unpublished.
AZD6234 is a once-weekly amylin receptor agonist. AstraZeneca registered several Phase 3 trials in 2026 covering obesity with and without type 2 diabetes, including a study adding it to an incretin drug.
Mechanism: Long-acting amylin receptor agonism that promotes satiety and slows gastric emptying.
Regulatory history: Investigational; Phase 3
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for AZD6234 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
AZD6234 in other countries
Frequently asked questions
Is AZD6234 legal in the United Kingdom?
No. AZD6234 is not approved for any medical use in the United Kingdom; its classification is "Investigational, not licensed". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.
Can I buy AZD6234 in the United Kingdom?
No approved product exists to buy. In the United Kingdom AZD6234 is classified as "Investigational, not licensed", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is AZD6234 MHRA approved?
No. In the United Kingdom AZD6234 is classified as "Investigational, not licensed", which is not a MHRA marketing approval. For comparison, the US FDA status is: Investigational; Phase 3. Evidence level: Preliminary.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for AZD6234 live on its compound profile.
AZD6234 profileThis page is general information about the regulatory status of AZD6234 in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.